Directory → Wegetotropona funds → Adrainoliticaskie funds → Альфа-адреноблокатор�� → Cornam
This page is translated automatically with a help of Google Translate
CornamSee also TerazosinRoman nameKornamThe composition and the form of1 tablet contains terzozina of monogidrohlorida digidrata 2 or 5 mg; blistere in 10 pcs. , in box 2 blisters.PharmacokineticsQuickly and completely absorbed from the gastrointestinal ingestion (eating does not affect the metabolism). C_max achieved through 1hr Metabolised in the liver; Most of the displays with jelchew. T_1/2-12 p.m. Pharmacokinetics in patients with renal insufficiency, elderly, and patients with moderate hypertension is different from the pharmacokinetics of the drug in patients with normal AD.FarmakodinamikaIs normalize lipid profile, plasma, reduces cholesterol, low-density and very low density. Perhaps that patients with peripheral obliteriruta angiopatiei. Has no adverse effects on the metabolic processes and can be used in patients with diabetes, asthma, Podagroy.lechenie terzozinom results in the reduction of the left thyroid heart.IndicationsTreating symptoms sound hyperplasia prostate cancer; Monotherapy hypertension low and moderate degree, treatment in combination with other antigipertenzivei of severe hypertension.Pregnancy and lactationContraindicated. At the time of treatment should stop breastfeeding.ContraindicationsHypersensitivity, pregnancy, breast-feeding, child.Patient interactionThe effect reinforces the other antigipertenzivee drugs. In clinical studies, while a NPVS, antibiotics, антихолинергических/��импатомиметических funds urikozuriceskih preparations antigistaminnah, oral lipid, corticosteroid, antatsidnykh, sedatives, trankviliziruth, dioreticakih PP and blocking �ета-адренорецепторов �liniceski significant effects have been detected.PrecautionsIn order to reduce the risk of hypotension ortostatichecka passed and treatment to start with the lowest dose (gradually increasing in the future) in the situation of lying, and under the supervision of a physician. Not recommended activities requiring concentration (drive vehicles, etc.) within 12 hours after the first dose, after its increase or suspension of the treatment. In controlled clinical studies in the treatment showed a reduction gematokrita, hemoglobin, white, albumin and total protein blood.Storage conditionsList B. The temperature is not above 25 ° CShelf life2The registration010202 |
All products of this group |

